Article

In contrast to T <sub>H</sub> 2-biased approaches, T <sub>H</sub> 1 COVID-19 vaccines protect Syrian hamsters from severe disease in the absence of dexamethasone-treatable vaccine-associated enhanced respiratory pathology

2021-12-28

Abstract excerpt

<h4>ABSTRACT</h4> Since December 2019, the novel human coronavirus SARS-CoV-2 has spread globally, causing millions of deaths. Unprecedented efforts have enabled development and authorization of a range of vaccines, which reduce transmission rates and confer protection against the associated disease COVID-19. These vaccines are conceptually diverse, including e.g. classical adjuvanted whole-inactivated virus, vir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86b77cf5-0287-57d3-9923-27028b1af81b
DOI: 10.1101/2021.12.28.474359

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In contrast to T <sub>H</sub> 2-biased approaches, T <sub>H</sub> 1 COVID-19 vaccines protect Syrian hamsters from severe disease in the absence of dexamethasone-treatable vaccine-associated enhanced respiratory pathologyDOI 10.1101/2021.12.28.474359Read

A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 VaccineSemantic proximity Read

A Broad-Spectrum Multi-Antigen mRNA/LNP-Based Pan-Coronavirus Vaccine Induced Potent Cross-Protective Immunity Against Infection and Disease Caused by Highly Pathogenic and Heavily Spike-Mutated SARS-CoV-2 Variants of Concern in the Syrian Hamster ModelSemantic proximity Read

Insights into standards of care – dexamethasone and antibodies against COVID-19 in hamster modelsSemantic proximity Read

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamstersSemantic proximity Read

Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamstersSemantic proximity Read

Updated vaccine protects from infection with SARS-CoV-2 variants, prevents transmission and is immunogenic against Omicron in hamstersSemantic proximity Read

Immunization with recombinant accessory protein-deficient SARS-CoV-2 protects against lethal challenge and viral transmissionSemantic proximity Read

A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsSemantic proximity Read

Dynamic Single-Cell RNA Sequencing Reveals that Intravenous BCG Vaccination Curtails SARS-CoV-2 Induced Disease Severity and Lung InflammationSemantic proximity Read

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-BSemantic proximity Read

A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamstersSemantic proximity Read

An attenuated vaccinia vaccine encoding the SARS-CoV-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human ACE2 transgenic mice from SARS-CoV-2 and its variantsSemantic proximity Read